Trends in age- and sex-specific prevalence and incidence of cardiovascular disease in Western Australia

European Journal of Preventive Cardiology
Danja SarinkAnna Peeters

Abstract

Background Temporal trends in incidence and mortality of cardiovascular disease (CVD) have been well described, with recent data suggesting declining improvements in those aged under 55 years. However, little is known about the combined impact of incidence and mortality trends on disease prevalence, an important indicator of disease burden and cost. We analysed changes in age-specific and age-standardised temporal trends in prevalence and incidence of CVD subtypes. Methods Annual prevalence and incidence rates of coronary heart disease, cerebrovascular disease and peripheral arterial disease for the Western Australian population for 1995-2010 were calculated using data from the Western Australian Data Linkage System. Joinpoint regression analyses were used to identify joinpoints in trends in age-specific and age-standardised annual prevalence and incidence rates for each CVD subtype. Results Between 1995 and 2010, age- and sex-specific incidence and prevalence of the CVD subtypes generally decreased among middle-aged and older adults, but were stable or increased among younger adults. In < 55 year olds, increases in incidence tended to occur from 2003, while increases in prevalence were from 2007/2008. Declines in age-standardi...Continue Reading

References

Nov 27, 1999·Australian and New Zealand Journal of Public Health·C D HolmanM S Hobbs
Jan 29, 2000·Statistics in Medicine·H J KimD N Midthune
Aug 13, 2003·International Journal of Epidemiology·Kate J BrameldMichael S T Hobbs
Jul 20, 2007·European Heart Journal·Alisha Ruth DaviesEmily Marjatta Dorothea Grundy
Feb 13, 2008·Archives of Internal Medicine·Peter N NemetzCynthia L Leibson
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·James D LewseyKate MacIntyre
May 26, 2010·Australian Health Review : a Publication of the Australian Hospital Association·Antony ClarkC D'Arcy J Holman
Feb 8, 2011·Lancet·Goodarz DanaeiUNKNOWN Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure)
Feb 8, 2011·Lancet·Mariel M FinucaneUNKNOWN Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index)
Feb 8, 2011·Lancet·Farshad FarzadfarUNKNOWN Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol)
Jul 26, 2011·International Journal of Cardiology·Thomas G BriffaMichael Hobbs
Aug 25, 2011·Circulation. Cardiovascular Quality and Outcomes·Lee J NedkoffMichael Hobbs
Jul 11, 2013·Stroke; a Journal of Cerebral Circulation·Annika RosengrenLena Björck
Jan 23, 2014·Lancet·Valery L FeiginUNKNOWN Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group
Jul 26, 2014·Journal of the American College of Cardiology·Aakriti GuptaHarlan M Krumholz
Nov 14, 2016·JAMA : the Journal of the American Medical Association·Ann Marie NavarMichael J Pencina
Feb 1, 2017·European Journal of Preventive Cardiology·Guy De Backer

❮ Previous
Next ❯

Citations

Dec 11, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Yueh-Han HsuChih-Cheng Hsu
Jan 17, 2020·European Journal of Preventive Cardiology·Veikko Salomaa
Apr 3, 2020·Journal of the American Heart Association·Rui DuUNKNOWN REACTION Study Group ‡
Aug 16, 2018·European Journal of Preventive Cardiology·Massimo F Piepoli
Jul 11, 2020·European Journal of Preventive Cardiology·Geza Halasz, Massimo F Piepoli
May 29, 2018·European Journal of Preventive Cardiology·Leonardo RoeverGiuseppe Biondi-Zoccai

❮ Previous
Next ❯

Software Mentioned

Joinpoint

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.